A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid Tumors
Clinical trial NCT05159388 · TERMINATED
Trial details
- NCT number
- NCT05159388
- Sponsor
- Servier Bio-Innovation LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2025-04-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.